Vitamin B12 influences circulation through several pathways, but the relationship is more complicated than supplement marketing suggests. When someone is genuinely deficient, restoring B12 levels can improve how blood flows, how blood vessels function, and how well the nervous system regulates blood pressure. In people who already have adequate B12, though, large clinical trials have consistently failed to show that extra supplementation protects against heart attacks, strokes, or other cardiovascular events. The distinction between correcting a deficiency and megadosing a nutrient you don’t lack turns out to be the whole story.
How B12 Shapes the Blood Itself
B12 is essential for making red blood cells. During their development in the bone marrow, immature red blood cells need B12 to copy their DNA properly. Without enough of it, those cells can’t divide normally and many of them die before maturing, a process called ineffective erythropoiesis that leads to anemia.1PubMed. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron The red blood cells that do survive tend to be abnormally large and misshapen, which changes the physical properties of blood in ways that matter for circulation.
A study of children with B12 deficiency found that their red blood cells were less flexible and clumped together more readily, while overall blood viscosity dropped. After treatment with B12, those cells became more deformable and clumping decreased, bringing blood-flow characteristics closer to normal. The researchers concluded that correcting B12 deficiency doesn’t just fix lab numbers on a blood test; it helps normalize the physical behavior of blood moving through small vessels.2PubMed. Investigation of hemorheological parameters at the diagnosis and the follow-up of nutritional vitamin B12 deficient children This matters most in capillaries and other tiny blood vessels, where stiff or sticky red blood cells have the hardest time squeezing through.
When anemia from B12 deficiency becomes severe, the heart compensates by pumping harder and faster to make up for the blood’s reduced oxygen-carrying capacity. As far back as the 1940s, physicians documented that pernicious anemia caused increased cardiac output and elevated heart rate as the body tried to deliver enough oxygen despite having fewer functional red blood cells.3Archives of Internal Medicine. Cardiovascular Manifestations in Pernicious Anemia Restoring B12 reverses this compensatory strain, bringing heart rate and cardiac output back toward normal.
The Homocysteine Connection
B12 plays a key role in recycling homocysteine, an amino acid that accumulates in the blood when B12 or folate is low. Elevated homocysteine damages the inner lining of blood vessels and promotes changes in arterial structure and function that set the stage for atherosclerosis.4PubMed Central. Role of homocysteine in the development of cardiovascular disease This observation fueled decades of research asking whether lowering homocysteine with B vitamins would prevent cardiovascular disease.
The logic seemed airtight: B12 deficiency raises homocysteine, high homocysteine injures arteries, so supplementing B12 should protect arteries. And B12 supplementation does reliably lower homocysteine. A recent meta-analysis found that B12 supplementation reduced homocysteine by a meaningful amount regardless of whether the vitamin was taken orally, under the tongue, or by injection.5Frontiers in Pharmacology. Efficacy of sublingual and oral vitamin B12 versus intramuscular administration: insights from a systematic review and meta-analysis The problem, as we’ll see, is that lowering homocysteine hasn’t translated into the cardiovascular payoff researchers expected.
Blood Vessel Function in Deficient Populations
For people who are actually low in B12, supplementation does appear to improve how blood vessels respond. A randomized trial in vegetarians with low B12 levels found that supplementation improved flow-mediated dilation, a measure of how well arteries expand when blood flow increases. The improvement was significant and continued to grow over six months. The artery walls also got measurably thinner, suggesting less early-stage plaque buildup. Interestingly, the improvement in artery function correlated with the rise in B12 itself rather than the drop in homocysteine, hinting that B12 may have direct vascular effects beyond just clearing homocysteine.6PubMed Central. Vitamin B-12 supplementation improves arterial function in vegetarians with subnormal vitamin B-12 status
That finding stands in contrast to what happens when you give B vitamins to people who aren’t deficient. A trial in elderly individuals with high homocysteine but not necessarily low B12 found that two years of B12 and folic acid supplementation made no difference to markers of endothelial function or inflammation compared to placebo.7PubMed. Effect of vitamin B12 and folic acid supplementation on biomarkers of endothelial function and inflammation among elderly individuals with hyperhomocysteinemia Another randomized trial of B-vitamin supplementation similarly found no significant change in flow-mediated dilation.8Journal of Clinical Biochemistry and Nutrition. Association between vitamin B group supplementation with changes in % flow-mediated dilatation and plasma homocysteine levels: a randomized controlled trial The pattern is consistent: if your B12 is low, fixing it helps your arteries. If your B12 is fine, adding more doesn’t do anything measurable.
Large Cardiovascular Trials Have Been Disappointing
The biggest blow to the “B12 for circulation” idea came from large-scale clinical trials designed to test whether lowering homocysteine with B vitamins prevents heart attacks and strokes. The HOPE-2 trial gave folic acid, B6, and B12 to over 5,000 patients with existing vascular disease for five years. Despite successfully lowering homocysteine, the supplements did not reduce heart attacks, cardiovascular deaths, or most other outcomes. There was a modest reduction in stroke risk, but also an unexpected increase in hospitalizations for unstable angina.9PubMed. Homocysteine lowering with folic acid and B vitamins in vascular disease
The SEARCH trial reinforced these findings with over 12,000 heart attack survivors followed for nearly seven years. Folic acid plus B12 reduced homocysteine by about 28%, yet there was no benefit whatsoever for major vascular events, coronary events, or stroke.10PubMed. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial Similarly, a two-year supplementation trial found no effect on arterial stiffness in elderly patients with high homocysteine.11PubMed. Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial
These trials enrolled patients who mostly had adequate B12 levels to begin with. What they tested was the idea that supraphysiological homocysteine lowering would prevent cardiovascular events, and the answer was clearly no. This doesn’t mean B12 is irrelevant to circulation. It means the homocysteine-lowering strategy, which was the main rationale for recommending B vitamins for heart health, didn’t pan out in people who weren’t deficient.
One Exception Worth Noting in Coronary Blood Flow
Not every trial was negative. A study of patients with stable coronary artery disease found that 24 months of folic acid plus B12 significantly increased both resting and stress-induced coronary blood flow compared to placebo or B6 alone. The researchers interpreted this as improved microvascular function in the small vessels feeding the heart muscle.12Coronary Artery Disease. Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12 This is an intriguing result, though it stands somewhat alone among the larger body of evidence. Whether improved coronary blood flow translates to fewer clinical events is unclear given the negative results of the bigger outcome trials.
Peripheral Artery Disease
People with peripheral artery disease, where narrowed arteries reduce blood flow to the legs, tend to have lower B12 levels than people without the condition. One study found that about 43% of patients with peripheral artery disease fell into the lowest quartile for B12, compared to 25% of controls.13PubMed. Vitamin B12 level in peripheral arterial disease But association isn’t causation. When researchers have looked at whether B12 intake actually predicts who develops peripheral artery disease, the picture weakens considerably.
A large prospective study of men found only a weak, non-significant inverse association between B12 and peripheral artery disease risk after adjusting for other factors.14The Journal of Nutrition. Intake of Folate, Vitamin B-6 and Vitamin B-12 and the Risk of Peripheral Arterial Disease in Men Another study looking at dietary B vitamins and peripheral artery disease risk found no significant association for B12 in either men or women.15Atherosclerosis. Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease Low B12 in peripheral artery disease patients may be a consequence of poor nutrition or other shared risk factors rather than a cause of the disease.
Blood Clots and Venous Thrombosis
B12 deficiency can raise homocysteine high enough to increase the risk of blood clots in veins. In a case-control study of patients with venous thromboembolism, about 17% had B12 levels below a key threshold, and among those with elevated homocysteine and clots, an abnormality in B12 or kidney function explained the elevated homocysteine in roughly 80% of cases.16PubMed. Vitamin B12 deficiency, hyperhomocysteinemia and thrombosis: a case and control study
This connection has practical relevance for people on metformin, a diabetes drug that can lower B12 levels over time. A case report described a diabetic patient on metformin who developed deep vein thrombosis alongside B12 deficiency and elevated homocysteine, with no other identifiable clotting risk factors.17Journal of the Formosan Medical Association. Hyperhomocysteinemia, Deep Vein Thrombosis and Vitamin B12 Deficiency in a Metformin-treated Diabetic Patient While a single case doesn’t prove causation, it aligns with the broader evidence that untreated B12 deficiency can create a pro-clotting state through homocysteine elevation.
When Your Blood Pressure Drops Upon Standing
B12 deficiency can disrupt the autonomic nervous system, the part of your nervous system that automatically adjusts your heart rate and blood vessel tone when you stand up. Research comparing B12-deficient patients to healthy controls found that the deficient group showed impaired ability to activate the sympathetic nervous system and adjust their blood pressure reflexes during posture changes. The pattern of dysfunction looked remarkably similar to what is seen in diabetic patients with established nerve damage.18PubMed. Autonomic dysfunction and hemodynamics in vitamin B12 deficiency
In at least one documented case, a 90-year-old woman with unexplained drops in blood pressure upon standing and near-fainting episodes was found to have low-normal B12 and no other explanation. Her symptoms resolved with B12 replacement.19PubMed Central. Orthostatic hypotension as a manifestation of vitamin B12 deficiency This is an underappreciated effect. If you feel lightheaded when you stand up and your B12 is borderline, the two could be connected, and it’s worth mentioning to a doctor.
The Metformin Problem
Metformin, the most widely prescribed diabetes medication worldwide, interferes with B12 absorption in the gut. Among metformin-treated patients, about 13% were frankly deficient and another 29% were borderline, with higher metformin doses correlating with lower B12 levels. That B12 drop drove homocysteine up, and the elevated homocysteine was independently associated with diabetic retinopathy, a microvascular complication that damages blood vessels in the eye.20PubMed. Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes
This creates a frustrating clinical scenario. Metformin protects against cardiovascular disease through its own mechanisms, but it may simultaneously promote vascular damage by depleting B12 and raising homocysteine. The growing evidence has led to increasing calls for routine B12 monitoring in long-term metformin users.21PubMed Central. Association between metformin and vitamin B12 deficiency in patients with type 2 diabetes For the millions of people taking metformin, periodic B12 checks are a simple safeguard with real circulatory implications.
Methylmalonic Acid as a Warning Sign
Standard B12 blood tests can miss early or functional deficiency. Methylmalonic acid, a metabolite that rises when B12 is insufficient at the cellular level, may be a more sensitive marker. A large cross-sectional analysis found that elevated methylmalonic acid was associated with roughly three times the odds of having cardiovascular disease, even after adjusting for traditional risk factors and B12 levels themselves.22PubMed Central. Increased serum methylmalonic acid levels were associated with the presence of cardiovascular diseases This doesn’t prove that methylmalonic acid causes cardiovascular disease, but it suggests that tissue-level B12 insufficiency, which might not show up on a basic blood panel, could be a more meaningful marker than serum B12 alone when assessing vascular risk.
B12 and Nitric Oxide
There’s a biochemical wrinkle that complicates the B12-circulation relationship. One form of B12, hydroxocobalamin, can scavenge nitric oxide, the molecule your blood vessels use to relax and widen. In animal studies, hydroxocobalamin raised blood pressure by soaking up nitric oxide, and this effect was clearly the mechanism behind its pressor action.23PubMed. Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile Lab work has confirmed that the reduced form of B12 has a high affinity for nitric oxide and binds it readily.24PubMed. Reactions of nitric oxide with vitamin B12 and its precursor, cobinamide
This is why hydroxocobalamin is used as an antidote for cyanide poisoning: it mops up both cyanide and nitric oxide. But the nitric oxide scavenging effect also means that very high doses of certain B12 forms could theoretically constrict blood vessels rather than relax them. At the doses found in standard supplements or dietary intake, this isn’t a practical concern. It does, however, illustrate that the biology of B12 and circulation isn’t a simple “more is better” equation.
Raynaud’s Phenomenon and Microvascular Spasm
Raynaud’s phenomenon, where fingers and toes turn white or blue in response to cold or stress because small blood vessels go into spasm, has a loosely explored connection to B12. In a study of children with primary Raynaud’s, about 42% had low B12 levels.25PubMed Central. Serum vitamin B12 and D levels in children with Primary Raynaud Phenomenon: a retrospective cohort study However, whether B12 was low mattered surprisingly little in terms of treatment outcomes. The need for vasodilator medication didn’t differ based on B12 status, while vitamin D deficiency did seem to matter. The evidence here is thin and doesn’t support taking B12 specifically for Raynaud’s, but it’s a reminder that nutritional deficiencies tend to cluster in people with circulatory problems.
How to Take B12 if You Need It
If you do have a B12 deficiency worth correcting, the delivery method matters less than you might think. A systematic review and meta-analysis comparing oral pills, sublingual tablets, and intramuscular injections found no significant difference between routes for raising B12 levels or lowering homocysteine.5Frontiers in Pharmacology. Efficacy of sublingual and oral vitamin B12 versus intramuscular administration: insights from a systematic review and meta-analysis A separate network meta-analysis also found no meaningful difference between routes for improving hemoglobin or other blood counts.26PubMed Central. Efficacy of different routes of vitamin B12 supplementation for the treatment of patients with vitamin B12 deficiency: A systematic review and network meta-analysis This is good news for anyone who dislikes needles. Oral supplementation works for most people, though doctors sometimes prefer injections initially for severe deficiency or when absorption problems like pernicious anemia are the underlying cause.
Pregnancy and Placental Blood Flow
B12 deficiency during pregnancy may impair the development of the placenta, the organ responsible for delivering blood and nutrients to the fetus. A review of the evidence found that low maternal B12 was linked to impaired placental development, increased placental inflammation, and altered levels of important fatty acids in placental tissue.27PubMed Central. Maternal Vitamin B12 in Pregnancy and Placental Development Since the placenta is fundamentally a circulatory organ connecting mother and baby, poor placental development from B12 deficiency represents a direct impact on a uniquely important vascular system. Prenatal vitamins typically include B12 for this reason, and women following vegan or vegetarian diets during pregnancy should be especially attentive to their B12 status.